Home › Neuroblastoma › Rhode Island › Providence
Neuroblastoma clinical trials in Providence, RI
3 studies for Neuroblastoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Hasbro Children's Hospital, Providence
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Rhode Island Hospital, Providence
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Rhode Island Hospital, Providence
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Obesity14 studies
- Endometrial Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Cancer (all types)12 studies
- Acute Myeloid Leukemia11 studies
- Crohn's Disease10 studies
- Ulcerative Colitis10 studies
- Overweight9 studies
- Metastatic Cancer9 studies
- Breast Cancer9 studies
- Alzheimer's Disease9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.